Product Images Isoproterenol
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 5 images provide visual information about the product associated with Isoproterenol NDC 69097-522 by Cipla Usa Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
This is a description of a drug called Isoproterenol Hydrochloride Injection, USP, manufactured by Cipla USA, Inc. The drug is intended for intravenous, subcutaneous, intramuscular, or intracardiac use only. The dosage is not specified, but the user can refer to the insert. The drug must be protected from light and kept in an opaque container until used. It comes in a 1mL ampule x 25 ampules per carton. The drug needs to be stored at 20°C to 25°C (68°F to 77°F), and the instructions warn against using it if the injection is pinkish, darker than slightly yellow, or contains a precipitate. The ampules have a color band to signify they are easy break ampules, and the tops snap off at the constriction, regardless of the position of the color band.*
This is a product label for Isoproterenol Hydrochloride B2 Injection, USP by Cipla Ltd. The drug is meant for intravenous, subcutaneous, intramuscular or intracardiac use only. The label indicates that the drug should be protected from light and is only available with a prescription. The batch number can be printed on a designated area of the label.*
This is a pharmaceutical product with the NDC code 69097-522-35. It is Isoproterenol Hydrochloride Injection, USP, with a strength of 1 mg/5 mL (0.2 mg/mL). It is for Intravenous, Subcutaneous, Intramuscular, or Intracardiac Use Only. The 5 mL ampoule comes in a carton of 10 ampoules. The area is left unvarnished for batch overprinting of product GTIN, Serial No., Expiry & Lot during commercial packing.*
This is a description of a medication called Isoproterenol Hydrochloride, which is available as an injection. The package includes a warning to protect it from light and to use it for intravenous, subcutaneous, intramuscular, or intracardiac administration only. The medication is manufactured by Cipla, India. The label also contains information on dosage. There is an unvarnished area for batch overprinting. The text mentions "Unwinding Direction" and "P e TN S," but it is not clear what they refer to.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.